Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Chemours (CC) Acquisitions (2019 - 2020)

Chemours has reported Acquisitions over the past 2 years, most recently at $10.0 million for Q3 2020.

Quarterly results put Acquisitions at $10.0 million for Q3 2020, changed 0.0% from a year ago — trailing twelve months through Sep 2020 was $20.0 million (up 100.0% YoY), and the annual figure for FY2019 was $10.0 million, down 72.97%.
Acquisitions for Q3 2020 was $10.0 million at Chemours, roughly flat from $10.0 million in the prior quarter.
Over the last five years, Acquisitions for CC hit a ceiling of $10.0 million in Q3 2019 and a floor of $10.0 million in Q3 2019.